Debut Plus

3.08

+0.01 +0.33%

18 Jul 2026

BSE Listed

GSM 0

Transgene Biotek Ltd. (526139)

Volume: 3,219Avg Vol 1W: 41,730Avg Vol 1M: 35,19152W Range:1.835.26
Market Cap₹23 Cr
Current Price₹3.08
Previous Close₹3.07
High / Low (52w)₹5.26 / ₹1.83
Volume3,219
Avg Vol (1W)41,730
Avg Vol (1M)35,191
Stock P/E
Book Value₹1.11
Dividend Yield0%
ROE-19.73%
ROA-114.85%
Revenue (TTM)
Revenue Growth
Profit Margin-825%
Total Debt
Shares Outstanding8 Cr
Face Value
EPS (TTM)₹0
P/B2.78
Debt / Equity1.38
50 DMA₹3.08
200 DMA₹3.05
Day change+0.33%
SurveillanceGSM 0 (as of 2026-07-18)
Price Chart
3.08 38.89% · 1Y
524.8L
2025-07-17
2026-07-17

20-day avg volume: 36K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 150% YoY.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹7 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EBITDA₹-5 Cr₹-9 Cr₹-11 Cr₹-10 Cr₹-10 Cr₹-6 Cr₹-1 Cr₹0 Cr
Net Profit₹-6 Cr₹-9 Cr₹-11 Cr₹-10 Cr₹-10 Cr₹-6 Cr₹-1 Cr₹-1 Cr
EPS-0.85-1.16-1.45-1.38-1.37-0.79-0.09-0.09
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹187 Cr₹177 Cr₹167 Cr₹157 Cr₹147 Cr₹142 Cr₹142 Cr₹144 Cr
Total Liabilities₹134 Cr₹133 Cr₹134 Cr₹135 Cr₹130 Cr₹131 Cr₹132 Cr₹134 Cr
Equity₹52 Cr₹44 Cr₹33 Cr₹22 Cr₹17 Cr₹11 Cr₹11 Cr₹10 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹-2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Investing₹3 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-2 Cr
Financing₹-2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Free Cash Flow₹-1 Cr₹-2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 23.64% Institutions 0% Public 76.36%
Efficiency & Working Capital
ROCE-2.3%
Interest Coverage-1.8
Dividend Payout
Debtor Days12 d
Inventory Days48 d
Payable Days2231 d
Cash Conversion Cycle-2172 d
Working Capital Days59 d
Shareholding Details

As of 2026-06-30

Promoter23.6%
FII0%
DII0%
Institutions0%
Public76.4%
Promoter Pledge0%
No. of Shareholders13,817
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters23.6%23.6%23.6%23.6%23.6%23.6%23.6%23.6%23.6%23.6%23.6%23.6%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public76.4%76.4%76.4%76.4%76.4%76.4%76.4%76.4%76.4%76.4%76.4%76.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders11,36012,22012,42612,76612,96313,30713,58313,47513,46113,54513,76713,817
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Dr K Koteswara RaoShareholding of Promoter and Promoter Group21.9%1.52 Cr
Kollipara NirmalaShareholding of Promoter and Promoter Group1.7%11,92,000
Kollipara SrinivasShareholding of Promoter and Promoter Group0%24,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Dr K Koteswara Rao00%2026-06-30
Kollipara Nirmala00%2026-06-30
Kollipara Srinivas00%2026-06-30
Dr K Koteswara Rao00%2026-03-31
Kollipara Nirmala00%2026-03-31
Kollipara Srinivas00%2026-03-31
Dr K Koteswara Rao00%2025-12-31
Kollipara Nirmala00%2025-12-31
Kollipara Srinivas00%2025-12-31
Dr K Koteswara Rao00%2025-09-30
Kollipara Nirmala00%2025-09-30
Kollipara Srinivas00%2025-09-30
Board of Directors
NameDesignationYear
K Koteswara RaoChairman & Managing Director2025
Sujana KadiamIndependent Non Exe. Director2025
Swetha MarriIndependent Non Exe. Director2025
Santosh KumarIndependent Non Exe. Director2025
Ankita JainCompany Secretary2025
Segments — Product
SegmentRevenueShare
Diagnostic Services₹0 Cr24.6%
CRO Services₹0 Cr75.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10767676
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000101
2025000101
2025000000
Company Information
Incorporated1990
ChairmanK Koteswara Rao
AuditorVasavi & Co
Investor Email[email protected]
🌐 www.transgenebiotek.com

📍 Plot No 69 & 70 IDA Bollaram, Sangareddy, Telangana, 502325

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search